🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Inhaled iloprost (Ventavis, BAYQ6256)

Found 15 matching trials

Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension

N/A

Local, prospective, multicenter, non-comparative, non-interventional, obser...

Status

Completed

Location

Multiple Locations

Start Date

2013-11-21

Trial ID

NCT01971450

Treatments Being Tested

Iloprost (Ventavis, BAYQ6256)

Efficacy of Ventavis Used in Real-life Setting.

N/A

This is a registry of patients diagnosed with pulmonary arterial hypertensi...

Status

Completed

Location

Multiple Locations

Start Date

2010-08-05

Trial ID

NCT01355380

Treatments Being Tested

Inhaled iloprost (Ventavis, BAYQ6256)

Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years

N/A

This is an open-label, uncontrolled, prospective long-term observation of S...

Status

Completed

Location

Multiple Locations

Start Date

2011-02-03

Trial ID

NCT01389271

Treatments Being Tested

Ventavis inhaled (Iloprost, BAYQ6256)

Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

N/A

The aim of this study is to examine inhalation behavior in patients enrolle...

Status

Completed

Location

Multiple Locations

Start Date

2016-09-15

Trial ID

NCT02826252

Treatments Being Tested

Iloprost,(Ventavis, BAYQ6256)I-Neb AAD system

Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension

N/A

The main aim of the observational VENTASTEP study was to investigate the as...

Status

Completed

Location

Many Locations

Start Date

2018-02-01

Trial ID

NCT03293407

Treatments Being Tested

Iloprost (Ventavis, BAYQ6256)Breelib nebulizer

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

PHASE1

Administration of iloprost aerosol comparing two nebulizers: FOX and I-Neb...

Status

Completed

Location

Multiple Locations

Start Date

2014-03-10

Trial ID

NCT02032836

Treatments Being Tested

lloprost(Ventavis,BAYQ6252, 20 µg/mL)lloprost(Ventavis,BAYQ6252, 10 µg/mL)

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

N/A

This is an observational study to monitor the continued effectiveness of Ve...

Status

Completed

Location

Multiple Locations

Start Date

2005-04

Trial ID

NCT00250640

Treatments Being Tested

Iloprost (Ventavis, BAYQ6256)

Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation

N/A

This pilot, non-interventional, company-sponsored, multi-center study docum...

Status

Completed

Location

Multiple Locations

Start Date

2013-09-23

Trial ID

NCT01894035

Treatments Being Tested

Iloprost (Ventavis, BAYQ 6256)

Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study

PHASE3

This study is to investigate the efficacy, safety, and Pharmacokinetics (PK...

Status

Completed

Location

Multiple Locations

Start Date

2012-06-19

Trial ID

NCT01469169

Treatments Being Tested

Iloprost (Ventavis inhaled, BAYQ6256)

Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients

N/A

This prospective, non-interventional, multi-center study documents observat...

Status

Completed

Location

Multiple Locations

Start Date

2013-09-11

Trial ID

NCT01781052

Treatments Being Tested

Ventavis (Iloprost, BAYQ6256)

Previous Next